Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as blood pressure, physical assessment, vital signs monitoring, diagnostic cardiopulmonary, diabetic retinopathy screening, and thermometry products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, and Monarch systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables; and operating room surgical safety and accessory products, which comprise scalpels and blades, light handle systems, skin markers, and other disposable products. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Phone312-819-7200
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.47 billion
Profitability
Miscellaneous
Employees10,000
OptionableOptionable
Hill-Rom (NYSE:HRC) Frequently Asked Questions
What is Hill-Rom's stock symbol?
Hill-Rom trades on the New York Stock Exchange (NYSE) under the ticker symbol "HRC."
How often does Hill-Rom pay dividends? What is the dividend yield for Hill-Rom?
Hill-Rom declared a quarterly dividend on Thursday, November 8th. Investors of record on Friday, December 14th will be given a dividend of $0.20 per share on Monday, December 31st. This represents a $0.80 annualized dividend and a yield of 0.76%. The ex-dividend date of this dividend is Thursday, December 13th. View Hill-Rom's Dividend History.
How were Hill-Rom's earnings last quarter?
Hill-Rom Holdings, Inc. (NYSE:HRC) posted its earnings results on Friday, January, 25th. The medical technology company reported $1.02 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.98 by $0.04. The medical technology company had revenue of $683.50 million for the quarter, compared to analysts' expectations of $676.39 million. Hill-Rom had a net margin of 7.21% and a return on equity of 21.23%. Hill-Rom's quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.92 EPS. View Hill-Rom's Earnings History.
When is Hill-Rom's next earnings date?
What guidance has Hill-Rom issued on next quarter's earnings?
Hill-Rom issued an update on its FY19 earnings guidance on Friday, January, 25th. The company provided earnings per share (EPS) guidance of $4.98-5.06 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.14. The company issued revenue guidance of $2.88-2.9 billion (+1-2%), compared to the consensus revenue estimate of $2.90 billion.Hill-Rom also updated its FY 2019 guidance to $4.98-5.06 EPS.
What price target have analysts set for HRC?
8 Wall Street analysts have issued twelve-month target prices for Hill-Rom's shares. Their forecasts range from $85.00 to $115.00. On average, they anticipate Hill-Rom's share price to reach $102.8750 in the next year. This suggests that the stock has a possible downside of 1.7%. View Analyst Price Targets for Hill-Rom.
What is the consensus analysts' recommendation for Hill-Rom?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hill-Rom in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Hill-Rom.
Has Hill-Rom been receiving favorable news coverage?
Media stories about HRC stock have been trending neutral this week, according to InfoTrie Sentiment. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Hill-Rom earned a news sentiment score of 0.4 on InfoTrie's scale. They also assigned news headlines about the medical technology company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
Who are some of Hill-Rom's key competitors?
Some companies that are related to Hill-Rom include ABIOMED (ABMD), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Penumbra (PEN), ICU Medical (ICUI), Insulet (PODD), Novocure (NVCR), Globus Medical (GMED), Haemonetics (HAE), Integra Lifesciences (IART), Cantel Medical (CMD), Merit Medical Systems (MMSI), NuVasive (NUVA) and Tandem Diabetes Care (TNDM).
Who are Hill-Rom's key executives?
Hill-Rom's management team includes the folowing people:
- Ms. Deborah M. Rasin, Sr. VP, Chief Legal Officer & Sec. (Age 51)
- Mr. Carlos Alonso-Marum, Sr. VP & Pres of International (Age 59)
- Mr. Steven J. Strobel, Sr. Advisor (Age 60)
- Mr. John P. Groetelaars, Pres, CEO & Director (Age 51)
- Ms. Barbara W. Bodem, Sr. VP & CFO (Age 50)
Who are Hill-Rom's major shareholders?
Hill-Rom's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (9.53%), Oregon Public Employees Retirement Fund (3.46%), Bank of Montreal Can (2.44%), Fisher Asset Management LLC (1.97%), Lord Abbett & CO. LLC (1.70%) and Bank of New York Mellon Corp (1.56%). Company insiders that own Hill-Rom stock include Alton Shader, Andreas G Frank, Deborah Rasin, John J Greisch, Mary Garrett and Paul Sherwood Johnson. View Institutional Ownership Trends for Hill-Rom.
Which major investors are selling Hill-Rom stock?
HRC stock was sold by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., Bank of America Corp DE, Lord Abbett & CO. LLC, Bank of Montreal Can, Jennison Associates LLC, Thrivent Financial for Lutherans, Prudential PLC and Royce & Associates LP. Company insiders that have sold Hill-Rom company stock in the last year include Alton Shader, Andreas G Frank, Deborah Rasin and Paul Sherwood Johnson. View Insider Buying and Selling for Hill-Rom.
Which major investors are buying Hill-Rom stock?
HRC stock was purchased by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Bank of New York Mellon Corp, BlackRock Inc., Two Sigma Investments LP, Channing Capital Management LLC, Squarepoint Ops LLC, Mackay Shields LLC and Mountain Pacific Investment Advisers Inc. ID. View Insider Buying and Selling for Hill-Rom.
How do I buy shares of Hill-Rom?
Shares of HRC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Hill-Rom's stock price today?
One share of HRC stock can currently be purchased for approximately $104.61.
How big of a company is Hill-Rom?
Hill-Rom has a market capitalization of $6.97 billion and generates $2.47 billion in revenue each year. The medical technology company earns $252.40 million in net income (profit) each year or $4.75 on an earnings per share basis. Hill-Rom employs 10,000 workers across the globe.
What is Hill-Rom's official website?
How can I contact Hill-Rom?
Hill-Rom's mailing address is 130 East Randolph Street Suite 1000, Chicago IL, 60601. The medical technology company can be reached via phone at 312-819-7200 or via email at [email protected]
MarketBeat Community Rating for Hill-Rom (NYSE HRC)
MarketBeat's community ratings are surveys of what our community members think about Hill-Rom and other stocks. Vote "Outperform" if you believe HRC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HRC will underperform the S&P 500 over the long term. You may vote once every thirty days.
